Local Tumor Necrosis Factor Alpha Exposure Inhibits Posterolateral Fusion Rates in a Rat Model

View at publisher
Authors: Mitchell K. Ng, John D. Koerner, Jonathan Dalton, Yasmine K. Eichbaum, Dipti Venkatesh, Mason Garcia, Alec Giakas, Alexander R. Vaccaro, Dessislava Markova, Christopher K. Kepler
Cited by: 2

Abstract

STUDY DESIGN: Randomized, preclinical animal study. OBJECTIVE: To determine whether exposure to TNF-α levels affects Mesenchymal stem cell (MSC) osteogenic differentiation and if brief, localized TNF-α at the fusion site affects posterolateral arthrodesis in a rat model. SUMMARY OF BACKGROUND DATA: Elevated tumor necrosis factor-α (TNF-α) has been shown in degenerative spine pathology, pseudarthrosis, and systemic inflammation. Yet the effect of local localized TNF-α exposure on subsequent arthrodesis remains incompletely understood. METHODS: MSCs were examined in vitro with TNF-α exposure. Bilateral posterolateral fusions at L4-L5 were performed on 35 Wistar Kyoto male rats. Demineralized bone matrix (DBM) was used for fusion in both groups, but the treatment group also received a low dose of TNF-α (20 uL of 50 ng/mL) on an absorbable collagen sponge. Animals sacrificed at day 2 and day 4 had the local fusion mass harvested and processed for cytokine analysis with ELISA. Serum was also collected by cardiac puncture. Animals sacrificed at 4 weeks were assessed by manual palpation and microCT for fusion, as well as serum cytokine levels with ELISA. RESULTS: TNF-α suppressed MSC osteogenesis in a dose-dependent manner, starting at 0.1 ng/mL. TNF-α protein rose within the fusion mass at postoperative day (POD) 2 in the treatment group compared to controls (P

Fields of Study & Subjects

Immune Response and Inflammation Orthopedic Infections and Treatments Orthopaedic implants and arthroplasty

Publication details

Journal / source
Spine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Publication date
2 April 2026
Language
EN